French questionnaire study for people with rheumatoid arthritis
Part of Bones, joints & muscles clinical trials.
This study checks whether a French questionnaire about rheumatoid arthritis care answers works well. You may help by completing the survey if you have rheumatoid arthritis and meet medication and consent requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and able to understand the study
- You must sign the consent form and agree freely to join
- You must have health insurance through a covered plan
- You must have rheumatoid arthritis and be on methotrexate (mouth or injections) for at least 3 months
- Your methotrexate dose and how you take it should be stable for at least 1 month, with no planned changes until the second visit
- You must not be in another interventional drug study at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with rheumatoid arthritis (RA) take their RA medicines—especially medicines like methotrexate and other targeted or biologic treatments. It may help improve medication adherence (taking doses correctly) and supports safer, more consistent treatment at home.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This study asks people with rheumatoid arthritis about their experiences and how it feels to join clinical trials. It may help researchers improve how future trials are done for patients like you.
This trial tests a personalized approach to find which of four biologic drugs works best for you if methotrexate didn't help or caused side effects. You'll get each drug in turn and track your symptoms to find your best match.
This trial studies an add-on treatment approach for rheumatoid arthritis (RA) in adults whose symptoms did not improve with standard “first-line” medicines. It may help people who still have active RA after trying certain disease-modifying drugs.
This study looks at how mood disorders (like depression or anxiety) affect people with chronic inflammatory joint diseases when they use biologic medicines. It may help doctors understand which patients are at higher mood-risk and how to monitor them.
Hear when a new Rheumatoid Polyarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.